Sign In

Gerard Honig

Leader in precision medicine R&D seeking to reduce suffering through technology ǀ Biomarkers ǀ Translational medicine ǀ Drug discovery ǀ R&D partnerships ǀ Biology of human disease ǀ Immunology

Gerard Honig is a research leader with a passion for reducing suffering through technology. With a background in clinical sciences, translational medicine, and mechanistic studies, Gerard has excelled in innovative drug discovery and product development to address unmet medical needs. His expertise includes biomarker strategies, genomics, transcriptomics, and proteomics, as well as statistical and machine learning-based data analysis methods. Gerard is adept at program management, strategic planning, and fostering collaborations across diverse biotech and nonprofit environments.

Highlights

May 22 · linkedin

Congratulations IRLAB Therapeutics AB on an exciting partnership with fantastic organizations The Michael J. Fox Foundation for Parkinson's Research & Otsuka Pharmaceutical Companies (U.S.) for initiation of an exciting clinical program focused on apathy in neurodegenerative disease!

https://lnkd.in/e3tZ_CM7

https://lnkd.in/eZvTdYPN

Oct 27 · linkedin

I hope this post finds you and yours safe and well. It's my pleasure to invite you to the 2023 Peggy Lillis Foundation 'Changing the Odds' Gala! The Peggy Lillis Foundation is a leading patient advocacy organization dedicated to reducing the suffering caused by C. difficile infection. This year's Gala will celebrate the great progress in this field in recent years and inspire the dedication and action that will be needed to continue this momentum. It's sure to be a fun and moving occasion. Please join us, and if you can't make it, check out our programming throughout the year and please consider making a donation to support this fantastic nonprofit organization that has done so much to raise awareness and advocate for the millions of people affected by this disease.

Gerard Honig
Add to my network

Location

Greater Philadelphia